Welcome to the PROG Holdings fourth quarter, 2024 earnings call. Joining me this morning are Steven Michaels, PROG Holdings President and Chief Executive Officer, and Brian Garner, our Chief Financial ...

Q4 2024 Earnings Call Transcript February 19, 2025 PROG Holdings, Inc. beats earnings expectations. Reported EPS is $0.8, ...

Q4 2024 Earnings Call Transcript February 21, 2025 Operator: Good afternoon, and welcome to the Travere Therapeutics Fourth ...

Richard Geary; Executive Vice President, Chief Development Officer; Ionis Pharmaceuticals Inc Elizabeth Hougen; Chief Financial Officer, Executive Vice President - Finance; Ionis Pharmaceuticals Inc ...

Q4 2024 Earnings Call Transcript February 20, 2025 2:30 AM ETCompany ParticipantsAmit Bhalla - Senior VP and Head ...

Q4 2024 Results Conference Call February 20, 2025 9:00 PM ETCompany ParticipantsJudy Tan - Investor Relation and ...

VANCOUVER, BC / ACCESS Newswire / February 18, 2025 / SNOWLINE GOLD CORP (TSXV:SGD)(OTCQB:SNWGF) (the "Company" or "Snowline") is honoured to announce its receipt of ECO Canada's Yukon Sustainability ...

Offering is expected to increase ADNOC Gas’ free float, enhance liquidity, and provide a clear pathway to MSCI and FTSE ...

Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...

Strategic investment underscores Wilo's commitment to sustainability, innovation, and supporting the UAE's economic vision. Dubai, U ...

WILMINGTON, DE, UNITED STATES, February 22, 2025 /EINPresswire / -- Allied Market Research published a new report, titled, Contingent Workforce Man ...

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers Halle (Saale) / Munich, Germany, February 19, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150 ...